166 related articles for article (PubMed ID: 32004327)
1. The impact of early adjuvant chemotherapy in rectal cancer.
Noh GT; Han J; Cho MS; Hur H; Lee KY; Kim NK; Min BS
PLoS One; 2020; 15(1):e0228060. PubMed ID: 32004327
[TBL] [Abstract][Full Text] [Related]
2. Time to adjuvant chemotherapy and survival outcomes among patients with stage 2 to 3 rectal cancer treated with preoperative chemoradiation.
Gresham G; Cheung WY; Speers C; Woods R; Kennecke H
Clin Colorectal Cancer; 2015 Mar; 14(1):41-5. PubMed ID: 25548075
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant Chemotherapy in Rectal Cancer Patients Treated With Preoperative Chemoradiation and Total Mesorectal Excision: A Multicenter and Retrospective Propensity-Score Matching Study.
Chung MJ; Lee JH; Lee JH; Kim SH; Song JH; Jeong S; Yu M; Nam TK; Jeong JU; Jang HS
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):438-448. PubMed ID: 30244158
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant Chemotherapy Use in Patients With Locally Advanced Rectal Cancer: A Single-Institution Experience.
Li F; Nielsen G; Baran A; Hu J; Wallace D; Preslar M; Fleming F; Temple L; Dunne RF; Noel M; Hezel AF; Tejani MA
Clin Colorectal Cancer; 2020 Sep; 19(3):e124-e128. PubMed ID: 32409226
[TBL] [Abstract][Full Text] [Related]
5. CoCStom trial: study protocol for a randomised trial comparing completeness of adjuvant chemotherapy after early versus late diverting stoma closure in low anterior resection for rectal cancer.
Sandra-Petrescu F; Herrle F; Hinke A; Rossion I; Suelberg H; Post S; Hofheinz RD; Kienle P
BMC Cancer; 2015 Nov; 15():923. PubMed ID: 26589718
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Chemoradiation Followed by Extensive Pelvic Surgery Improved the Outcome of Posterior Invasive Locally Recurrent Rectal Cancer without Deteriorating Surgical Morbidities: A Retrospective, Single-Institution Analysis.
Ogawa H; Uemura M; Nishimura J; Hata T; Ikenaga M; Takemasa I; Mizushima T; Ikeda M; Sekimoto M; Yamamoto H; Doki Y; Mori M
Ann Surg Oncol; 2015 Dec; 22(13):4325-34. PubMed ID: 25893408
[TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy without radiotherapy for patients with locally advanced rectal cancer. Oncologic outcomes.
Cienfuegos JA; Rodríguez J; Baixauli J; Chopitea Ortega A; García-Consuegra A; Abengózar M; Sánchez Justicia C; Hernández Lizoain JL
Rev Esp Enferm Dig; 2020 Jan; 112(1):16-22. PubMed ID: 31729235
[TBL] [Abstract][Full Text] [Related]
9. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
[TBL] [Abstract][Full Text] [Related]
10. Association of Adjuvant Chemotherapy With Overall Survival in Patients With Rectal Cancer and Pathologic Complete Response Following Neoadjuvant Chemotherapy and Resection.
Polanco PM; Mokdad AA; Zhu H; Choti MA; Huerta S
JAMA Oncol; 2018 Jul; 4(7):938-943. PubMed ID: 29710272
[TBL] [Abstract][Full Text] [Related]
11. Impact of timing of adjuvant chemotherapy following radical cystectomy for bladder cancer on patient survival.
Grunewald CM; Henn A; Galsky MD; Plimack ER; Harshman LC; Yu EY; Crabb SJ; Pal SK; Alva AS; Powles T; De Giorgi U; Agarwal N; Bamias A; Ladoire S; Necchi A; Vaishampayan UN; Sternberg CN; Bellmunt J; Baniel J; Niegisch G
Urol Oncol; 2020 Dec; 38(12):934.e1-934.e9. PubMed ID: 32660788
[TBL] [Abstract][Full Text] [Related]
12. Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery.
Kim CG; Ahn JB; Shin SJ; Beom SH; Heo SJ; Park HS; Kim JH; Choe EA; Koom WS; Hur H; Min BS; Kim NK; Kim H; Kim C; Jung I; Jung M
BMC Cancer; 2017 Sep; 17(1):615. PubMed ID: 28865435
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy may improve disease-free survival in patients with rectal cancer positive for MRI-detected extramural venous invasion following chemoradiation.
Chand M; Rasheed S; Heald R; Swift I; West N; Rao S; Tekkis P; Brown G
Colorectal Dis; 2017 Jun; 19(6):537-543. PubMed ID: 27673438
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy for locally advanced rectal cancer in elderly patients after neoadjuvant chemoradiotherapy and surgery: Toxicity and survival outcomes.
Sun Q; Liu T; Liu P; Lu K; Zhang N; Liu L; Zhu Y
Medicine (Baltimore); 2020 Jan; 99(4):e18835. PubMed ID: 31977879
[TBL] [Abstract][Full Text] [Related]
15. Effect of Adjuvant Chemotherapy on Stage II Rectal Cancer Outcomes After Preoperative Short-Course Radiotherapy.
Loree JM; Kennecke HF; Renouf DJ; Lim HJ; Vickers MM; Speers CH; Cheung WY
Clin Colorectal Cancer; 2016 Dec; 15(4):352-359.e1. PubMed ID: 27265355
[TBL] [Abstract][Full Text] [Related]
16. A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC).
Oki E; Murata A; Yoshida K; Maeda K; Ikejiri K; Munemoto Y; Sasaki K; Matsuda C; Kotake M; Suenaga T; Matsuda H; Emi Y; Kakeji Y; Baba H; Hamada C; Saji S; Maehara Y
Ann Oncol; 2016 Jul; 27(7):1266-72. PubMed ID: 27056996
[TBL] [Abstract][Full Text] [Related]
17. Analysis of delay in adjuvant chemotherapy in locally advanced rectal cancer.
Farzaneh CA; Pigazzi A; Duong WQ; Carmichael JC; Stamos MJ; Dekhordi-Vakil F; Dayyani F; Zell JA; Jafari MD
Tech Coloproctol; 2023 Jan; 27(1):35-42. PubMed ID: 36042105
[TBL] [Abstract][Full Text] [Related]
18. Postoperative adjuvant chemotherapy in rectal cancer operated for cure.
Petersen SH; Harling H; Kirkeby LT; Wille-Jørgensen P; Mocellin S
Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD004078. PubMed ID: 22419291
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial.
Breugom AJ; van Gijn W; Muller EW; Berglund Å; van den Broek CBM; Fokstuen T; Gelderblom H; Kapiteijn E; Leer JWH; Marijnen CAM; Martijn H; Meershoek-Klein Kranenbarg E; Nagtegaal ID; Påhlman L; Punt CJA; Putter H; Roodvoets AGH; Rutten HJT; Steup WH; Glimelius B; van de Velde CJH
Ann Oncol; 2015 Apr; 26(4):696-701. PubMed ID: 25480874
[TBL] [Abstract][Full Text] [Related]
20. Association Between Adjuvant Chemotherapy and Overall Survival in Patients With Rectal Cancer and Pathological Complete Response After Neoadjuvant Chemotherapy and Resection.
Dossa F; Acuna SA; Rickles AS; Berho M; Wexner SD; Quereshy FA; Baxter NN; Chadi SA
JAMA Oncol; 2018 Jul; 4(7):930-937. PubMed ID: 29710274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
